Log In
Print
BCIQ
Print
Print this Print this
 

GX301

  Manage Alerts
Collapse Summary General Information
Company Mediolanum Farmaceutici S.p.A.
DescriptionTelomerase-based vaccine
Molecular Target
Mechanism of ActionVaccine
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationProstate cancer
Indication DetailsTreat prostate cancer
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today